Legal Representation
Attorney
Gabrielle A. Holley
USPTO Deadlines
Application History
14 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Aug 1, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| Jan 31, 2025 | RCSC | S | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | Loading... |
| May 23, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 23, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 23, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Apr 23, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 23, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 23, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 26, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 26, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 22, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 2, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 3, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Biochemicals, namely, antibodies and fragments thereof for research and development; biochemicals, namely, antibodies and fragments thereof and polypeptides for general manufacturing; biochemicals, namely, antibodies and fragments thereof and polypeptides for use in the manufacture of pharmaceuticals for the treatment of oncological and autoimmune diseases and disorders
First Use Anywhere:
Oct 23, 2002
First Use in Commerce:
Oct 23, 2002
Class 005
Pharmaceutical preparations, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders
First Use Anywhere:
Oct 23, 2002
First Use in Commerce:
Oct 23, 2002
Class 042
Product development consulting in the fields of biotechnology and pharmaceuticals; product development for others in the fields of biotechnology and pharmaceuticals
First Use Anywhere:
Oct 1, 1997
First Use in Commerce:
Oct 1, 1997
Classification
International Classes
001
005
042